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Abstract 
Escherichia coli O157:H7 is a human food-borne pathogen and cattle feces are a major 
source of contamination.  Immunization against E. coli O157 may be a practical pre-harvest 
intervention strategy.  A siderophore receptor/porin proteins (SRP) based vaccine has been 
developed to decrease the prevalence of E. coli O157 in cattle.  Two studies were conducted to 
determine the efficacy of the SRP vaccine. 
In the first study, thirty calves were randomly assigned to one of two groups: control or 
SRP vaccine.  Two weeks after the second vaccination, calves were orally inoculated with 
nalidixic acid-resistant (Nal
R
) E. coli O157.  Fecal samples were collected for five weeks.  
Calves were necropsied on day 35 to collect gut contents and tissue swabs to determine Nal
R
 E. 
coli O157:H7.  The number of calves that were culture positive for E. coli O157 were lower (P= 
0.07) in vaccinated group compared to the control.   
In the second study, cattle in two feedlots were randomized to SRP vaccine or control.  
Cattle were vaccinated on days 0 and 21.  Rectal fecal samples were collected on day 0, and pen 
floor samples were collected on days 21, 35, and 70.  Rectal fecal samples, RAMS, and hide 
swab samples were collected on d 85.  Cattle were weighed on days 0, 21, and 85.  Vaccination 
significantly reduced (P = 0.04) fecal E. coli O157 prevalence.  There was also a decrease (P < 
0.05) in E. coli O157 prevalence on hides and in fecal samples on day 85 in vaccinated cattle 
compared to the control.   
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Preface 
The last two chapters in this thesis entitled:  “Siderophore Receptor/Porin Proteins-based 
Vaccination Reduces Prevalence and Shedding of Escherichia coli O157:H7 in Experimentally 
Inoculated Cattle”, and “Effect of siderophore receptor/porin proteins-based vaccination on 
prevalence of Escherichia coli O157:H7 in feedlot cattle” were submitted for publication in the 
Journal of Food Protection and the American Journal of Veterinary Research, respectively.  The 
text and figures within these chapters are formatted according to the guidelines that were 
specified by the journal.    
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CHAPTER 1 - LITERATURE REVIEW 
 
Escherichia coli O157 
Enterohemorrhagic E. coli O157:H7 is pathogenic microorganism that can cause severe 
hemorrhagic colitis, thrombocytopenic purpura, and hemolytic uremic syndrome (HUS) in 
humans.  Illness usually occurs in children under the age of five, the elderly, and those who are 
immunosuppressed (Park et al., 1999). Based on an epidemiological study conducted in 1999, 
the CDC estimates that there are nearly 73,000 illnesses due to E. coli O157:H7 occurring 
annually in the United States.  In 2006, specific outbreaks of E. coli O157:H7 were reported in 
more than 26 states affecting over 300 people and hospitalizing more than half of the population 
that was infected.  Of those hospitalized, 39 people developed severe kidney failure and three 
people died (CDC, 2006).   
Escherichia coli O157 is a Gram negative, rod-shaped, facultative anaerobe that is normally 
harbored in the intestines of healthy ruminants making manure an important source of 
environmental contamination (Rasmussen et al., 2001; Bach et al., 2002; CDC, 2006).   
According to Elder et al. in 2000, the prevalence of E. coli O157 is 11 to 28% in cattle feces, 
11% on hides, and 3 to 28% on carcasses.   Modes of transmission of this pathogen to humans 
are consumption of contaminated fruits and vegetables, consumption of improperly cooked 
contaminated ground beef, direct contact with animals (petting zoos), and exposure to 
contaminated water (Callaway et al., 2004).  
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Colonization and Virulence of E. coli O157 
In order to effectively reduce the number of E. coli O157 shed by cattle and further reduce 
the risk of human illness, the bacteria’s means of invading its host must be evaluated and 
understood.  The ability of this organism to colonize in the intestines of its host requires several 
bacterial proteins which are important for proper attachment to the intestinal epithelial cells 
(Moxley, 2004).  Intimin, which is encoded by the eae gene, is a bacterial outer membrane 
protein that mediates the intimate attachment of E. coli 0157 to the intestinal epithelial cells. This 
attachment leads to the formation of A/E lesions which are encoded by the locus of enterocyte 
effacement (LEE) pathogenicity island (Gyles, 2007). The translocated intimin receptor (Tir), 
encoded by the tir gene, is a bacterial protein that is delivered to the host cell where it functions 
as a receptor for intimin.  E. coli secreted proteins, or Esps, are proteins secreted by the type III 
secretion system which aid in bringing Tir into the host cell.  Secretion proteins include:  EspA 
which forms a filamentous structure that bridges the bacterial surface to the host cell’s surface, 
EspB which is delivered into the host cell membrane where it becomes an integral membrane 
protein, and EspD which along with EspB, forms a pore structure in the membrane of the host 
cell (Kaper et al., 1998). Once the pathogen has invaded its host, it rearranges the cytoskeleton of 
each cell forming a pedestal where the bacteria then attach and reside (Vallance and Finlay, 
2000).  
Shiga toxins (Stx1 and Stx2) are two virulence factors that are very toxigenic to humans.  
Stx1 and Stx2 are both verotoxins that closely resemble those of Shigella dysenteria.  Shiga toxin 
1 is a toxin that is commonly found in sheep and causes little to no disease in humans (Friedrich 
et al., 2004).  In contrast, Shiga toxin 2 tends to cause severe endothelial damage and is 
responsible for acute renal failure (HUS) and bloody diarrhea in humans (Kaper et al., 1998). 
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The O-antigen, or lippopolysacharride (LPS), and the H-antigen, which represents the 
flagella, are antigens that also play key roles in virulence (Gyles, 2007).  LPS is a large complex 
molecule that is made up of lipids and carbohydrates (Prescott et al., 2005).  It is very heat stable 
and consists of three unique parts:  1) the lipid A region, which is buried in the outer membrane 
of the bacterial cell and is responsible for toxicity of the LPS, 2) the inner and outer core region, 
which consists of several sugars that are needed for viability of the cells, and 3) the O-side chain, 
which is an antiphagocytic polysaccharide that extends outward from the core and is a major 
surface antigen for the bacteria (Prescott et al., 2005).    
The H-antigen, or flagellar antigen, encoded by the fliC gene, is responsible for the 
movement of the microorganism within its host and is a major contributor to inflammation in 
humans (Gyles, 2007). E. coli O157:H7 has seven lophotrichous flagella (“H7”) that according 
to Berin et al. in 2002 play an important role in signaling proinflammatory cytokines (IL-8) in 
the human colonic epithelial cells.  Researchers have found that the deletion of the fliC gene 
allows shiga-toxin producing E. coli to become less virulent (Gyles et al., 2007).  Without 
flagella, bacteria cannot travel as effectively, thus, reducing the spread of the organism within 
the host (Prescott et al., 2005).     
Environmental Conditions affecting prevalence of E. coli O157       
Temperature and environmental conditions can often contribute to microorganism’s ability to 
thrive and therefore increase the exposure of the host animals. According to Hancock et al. in 
1997, studies have shown that peak prevalence of E. coli O157 in cattle occurs in the late 
summer and early fall months in North America.  This also correlates with documented increases 
in human cases of hemorrhagic colitis occurring from July to August relative to other times of 
the year (Armstrong, et al. 1996).  E. coli O157 has been found to survive in manure for several 
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days at 37 degrees Celsius and for several months at 4 degrees Celsius due to its heat stable 
lippopolysaccharide (Wang et al, 1996; Kudva et al., 1998).  Edrington et al. (2006) determined 
that there was a strong correlation between E. coli O157:H7 prevalence and day length. They 
found that after exposing four pens of cattle to an additional four hours of artificial daylight that 
experimentally infected cattle shed higher levels of E. coli O157:H7 than control cattle after 60 
days of exposure (Edrington et al., 2006). 
 Smith et al. in 2001 found that there was a higher prevalence in cattle shedding E. coli 
O157:H7 in pens with muddy conditions when compared to cattle shedding in pens with normal 
conditions.  This suggests that the condition of the pen floor may increase prevalence of fecal 
shedding of E. coli due to the increase exposure rate of cattle through drinking of contaminated 
ground water, increased contamination of the feed and intended water source, or increased stress 
on the cattle with the muddy conditions.  Another study has shown that this organism is not only 
isolated from the feces of cattle (0.8%), but can also be isolated from feedbunks (1.7%), water 
troughs (12%), and incoming water supplies (4.5%) (Van Donkersgoed et al., 2005).  These 
contaminated fomites may not only increase prevalence in cattle, but may also increase the 
chance of the organism to contaminate the environment. 
Other environmental factors that may influence prevalence of E. coli O157 are house flies 
(Musca domestica L.).  In 2006, eight calves were individually exposed to flies that were orally 
inoculated with a mixture of four strains of nalidixic acid-resistant (Nal
R
) E. coli O157:H7. One 
day after exposure, all eight calves tested positive for the challenged organism.  The fecal 
concentration of the Nal
R 
E. coli O157:H7 in exposed calves reached levels as high as 1.1 x 10
6
 
CFU/g.  Calves remained positive for up to 11 days and 62% remained positive until the end of 
the study (Ahmad et al., 2007).      
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Intervention and Prevention 
Farmers and scientists have been collaborating for the past twenty years to try to develop an 
appropriate pre/post-harvest intervention strategy to reduce E. coli O157 in cattle.  Pre-harvest 
intervention would essentially reduce contamination of the microorganism in the environment, 
while post-harvest intervention would decrease contamination of beef products as the cattle are 
harvested.  Pre-harvest strategies that are currently being researched to further reduce food borne 
illness include:   probacterial/prebacterial intervention, the use of traditional antibiotics, 
bacteriophage therapy, dietary changes, and immunization.   
Probiotics 
According to Schrezenmeir and de Vrese (2001) probiotics are “products containing 
microorganisms in sufficient numbers which alter the microflora within the host and cause 
beneficial health effects.”  These microorganisms cause competitive exclusion within the gut and 
essentially out-compete harmful bacteria for nutrients or receptor sites (Buchanan and Doyle 
1997).  Studies have shown that feeding a mixture of non-pathogenic strains of E. coli and 
Proteus mirabilis to cattle reduces colonization of E. coli O157 in the rumen and in the feces 
(Zhao et al., 1998).  Escherichia coli strains capable of producing colicin E7 were also found to 
reduce (1.8 log10CFU/g) serotype O157:H7 when administered to calves prior to oral challenge 
with nalidixic acid-resistant E. coli O157:H7.  Colicins are antimicrobial proteins that are 
produced by some E. coli strains under high stress conditions and give that particular strain of 
bacteria a competitive advantage over pathogenic strains in the gut (Schamberger et al., 2004). 
Additional studies conducted by Brashears et al. (2003) showed that Lactobacillus-based 
direct-fed microbials were effective in decreasing E. coli O157 in the feces and on hides of 
feedlot cattle.  Lactobacillus acidophilus, particularly strain NP51, significantly reduced the 
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number of cattle shedding O157 resulting in the probability that “NP51 treated steers were 35% 
less likely to shed E. coli O157:H7 than control steers during a two year (2002-2003) period 
(Peterson, et al., 2007).”     
Prebiotics 
Oral prebiotics are another method used to out-compete pathogenic microorganisms for 
nutrients and space within the gut.  Prebiotics are oligosaccharide polymers that are indigestible 
to the host and are highly digestible by commensal bacteria (LeJeune and Wetzel, 2007).  
Increasing the amount of nutrients available for commensal bacteria often creates an unfavorable 
environment for pathogens in means of space and nutrients.  The addition of four fementable 
carbohydrates (lactulose, inuin, wheat starch, and sugar beet pulp) where found to support 
growth of specific lactobacilli species (Lactobacillus amylovorus-like phylotype) in weaning 
piglets (Konstantinov et al. 2003).  In 2007, an in vitro and in vivo trial was conducted to 
examine the effects of Cassiae Seeds (PCS) on improving the intestinal microflora of baby pigs 
(Deng et al. 2007).  They found that there was a significant increase in Lactobacilus counts when 
0.8% PCS was added to rejuvenation fluid and cecum content.  Piglets (6.5 kg) were then fed 
diets supplemented with or without 0.4% or 0.8% PCS and upon necropsy, piglets that were fed 
0.8% PCS had significantly more caecal bacterial microflora than those fed a normal ration or 
supplemented with 0.4% PCS.  The use of prebiotics was, also, found to be beneficial in 
improving intestinal health of humans, yet little research has been done to test these products on 
cattle (de Vaux et al., 2002).  
Antimicrobial Compounds 
The administering of traditional antibiotics in cattle has been shown to effectively reduce E. 
coli O157:H7 in cattle.  Neomycin sulfate has been tested in feedlot cattle and was found to 
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significantly decrease shedding of E. coli O157 in the feces and contamination on hides (98.2% 
and 95.0% reduction, respectively) (Loneragan and Brashears, 2005). Neomycin is an 
antimicrobial drug that is administered in the feed or in water and is used to treat colibacillosis in 
cattle (G.H. Loneragan and Brashears, 2005).  The use of antibiotics as growth promotants in 
cattle has become a highly controversial topic making this form of intervention a less desirable 
strategy.  “Bacteria have many complex mechanisms to resist antibiotics, and the widespread use 
of antibiotics in both human and animal medicine has led to the widespread dissemination of 
antibiotic resistance genes” (Callaway, et al., 2004).    Although Neomycin is closely related to 
antibiotics that are used to treat human illness (aminoglycoside family) and may form a risk 
associated with antimicrobial residues,  it is an ideal antibiotic for use in the cattle industry 
because it has a 24-hour withdrawal period (J.T. LeJeune and A.N. Wetzel, 2006, T.R. Callaway 
et al., 2003, Loneragan and Brashears, 2005).  This allows for the proper reduction of E. coli 
O157:H7 to take place just prior to slaughter, thus reducing the risk of carcass contamination and 
further reducing the risk of food borne illness. 
Supplementing sodium chlorate in the cattle’s drinking water is another method used to 
reduce E. coli O157:H7.  This was tested in 2002 on four ruminally fistulated and four 
nonfistulated , nonlactating Holstein cows that were experimentally infected with three strains of 
E. coli O157:H7 (T.R. Callaway et al., 2003). Results indicated that a 24- hour treatment with 
sodium chlorate reduced E. coli O157:H7 by two logs (10
4
 to 10
2
) in the feces and by three logs 
(10
6
 to 10
3
) in the rumen. Sodium chlorate was described as a beneficial strategy because as 
chlorate is reduced to chlorite, by nitrate reductase, anaerobic bacteria die due to the chlorites 
bactericidal effects (T.R. Callaway et al. 2003; J.T. LeJeune and A. N. Wetzel, 2007).  Though 
this chemical may be a beneficial strategy for reducing E. coli O157:H7 in the gut, it may 
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negatively impact beneficial microbial populations in the rumen, leading to a reduction in cattle’s 
performance (J. T. LeJeune and A.N. Wetzel, 2007).    
Bacteriophages 
Another potential preharvest intervention strategy used to reduce E. coli O157:H7 in cattle 
are the use of bacterophages.  Bacteriophages are live viruses that are highly specific and can be 
used to kill bacterial pathogens within a mixed microbial population (T. R. Callaway, et al., 
2003; J. T. LeJeune and Wetzel, 2007; Prescott et al., 2005).  Bacteriophages have the ability to 
incorportate their DNA within the bacterial host’s DNA, allowing the number of phages to 
increase exponentially, essentially exhausting all of the host’s nutrients (Prescott et al., 2005; 
Callaway, et al., 2003).   
Several research trials have been conducted on a variety of species to further examine the 
effects of bacteriophage therapy on reducing food borne pathogens (Tanji et al., 2005; Kudva et 
al., 1999; O’Flynn et al., 2004; Sheng et al., 2006).  In 1999, researchers from the University of 
Idaho isolated and tested 53 Escherichia coli O157 antigen-specific bacteriophages from bovine 
and ovine fecal samples (Kudva, et al. 1999).  Five of these phages were found to be E. coli 
O157 specific and three of these lytic phages (KH1, KH4, and KH5) lysed E. coli O157 after five 
days incubation at 4 degrees Celsius.   
Sheng et al. in 2006 continued this research by orally administering a mixture of the 
previously tested bacteriophages (KH1 and SH1) to experimentally infected mice and found that 
phage treatment eliminated E. coli O157:H7 2 to 6 days after oral challenge.  Phages were 
applied to the rectoanal junction mucosa of five Holstein steers and results indicated that there 
was a significant decrease in the concentration of E. coli O157:H7 when phage-treated steers 
were compared to the controls.  This treatment did not, however, eliminate the bacteria in the gut 
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of most steers and did not reduce intestinal E. coli O157:H7 when the phage therapy was 
administered to sheep (Sheng et al., 2006).  The use of bacteriophage therapy in food animals 
unfortunately is not frequently reported and further use of this intervention in the “real-world” 
setting may not be beneficial due to highly aerated conditions that are needed for this therapy to 
be effective (Kudva et al., 1999; Bach et al., 2002; Callaway et al., 2004).   
Dietary Influence 
Dietary changes may also influence the amount of E. coli O157:H7 found in the 
gastrointestinal tract of cattle (Duncan et al., 2000; Bach et al., 2002; Callaway et al., 2003; 
LeJeune and Wetzel, 2003).  High concentrate diets that are fed to cattle during the finishing 
period often results in an increase of volatile fatty acids, which decreases the ruminal pH which 
creates an ideal environment for acid-resistant E. coli O157 (Bach et al., 2002).  Published 
literature describing the effects of diet and diet change on the shedding of E. coli O157:H7 in 
ruminants have been controversial and inconclusive (Bach et al., 2002; Callaway et al., 2003; 
LeJeune and Wetzel, 2003).  Some scientists have found that feeding forage-based diets allows 
animals to shed E. coli O157 longer than animals fed a grain-based diet (Hovde, et al. 1999), yet 
other scientists found that cattle that were abruptly switched from a finishing ration to 100% hay 
allowed fecal E. coli populations in the gut to decline 1,000-fold (Diez-Gonzalez et al., 1998; 
Hovde et al., 1999; Callaway et al., 2003; Van Baale et al., 2004).  
Ingredients such as corn, barley, and canola oil have also been tested as dietary factors that 
may influence prevalence of E. coli O157 (Buchko et al., 2000; Berg et al., 2003; Bach et al., 
2005).   Buchko et al. in 2000 reported that there were significantly more animals culture 
positive for E. coli O157 when cattle were fed a finishing ration of 85% barley compared to 
cattle fed a finishing ration of 85% cracked corn.  Berg et al. reported a similar hypothesis and 
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found that the average fecal concentration of E. coli O157 in cattle fed a barley-based diet 
compared to those fed a corn-based diet was 3.3 log CFU/g and 3.0 log CFU/g respectively.  The 
addition of canola oil to the finishing ration was reported to have no affect on shedding of E. coli 
O157:H7 in feedlot cattle (Bach et al., 2005). 
Fasting is a method commonly used to reduce contamination of hides prior to cattle being 
harvested (Stevens et al., 2002). The effect of dietary stress on fecal shedding of Escherichia coli 
O157:H7 in calves orally inoculated with 10
10
 CFU/animal was tested and revealed that  
withholding food for 48 hours after oral challenge did not significantly increase fecal shedding of 
E. coli O157 (Cray et al., 1998).  Food withheld 48h prior to inoculation with 10
7
 CFU/g of E. 
coli O157:H7 did result in a significant increase in the concentration of E. coli O157:H7 (1.4x10
4 
CFU/g vs. 3.5x10
5 
CFU/g; control vs. fasted, respectively
) 
when fasted calves were compared to 
the controls (Cray et al., 1998).  Kudva et al. (1995) witnessed the same phenomenon in sheep.  
They found that withholding feed prior to inoculation with E. coli O157 not only allowed the 
animals to shed bacteria at increased levels, but also increased the animal’s susceptibility to other 
infections (Kudva et al., 1995).  Fasting can cause the rumen pH to rise and the concentration of 
volatile fatty acids to drop, allowing for proliferation of E. coli O157:H7 due to favorable 
environmental conditions (Kudva et al., 1995).  This suggests that interventions aimed at 
reducing food borne illness should be administered when cattle are experiencing dietary stress so 
that the spread of these pathogenic microorganisms is limited (Cray et al., 1998).     
Vaccination 
Exploiting the animal’s immune system in order to decrease pathogenic microorganisms in 
the gastrointestinal tract is yet another intervention strategy that is currently being tested 
(Callaway et al., 2004; LeJeune and Wetzel, 2007, Bach et al., 2002).  The use of vaccination to 
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prevent colonization of an organism that is a commensal in cattle can often be challenging.  
Nonetheless, investigators have developed and administered experimental vaccines containing 
proteins and cellular components that play key roles in bacterial adherence to the epithelial lining 
of the intestinal mucosa (LeJeune and Wetzel, 2007).   Dean-Nystrom in 2002 used passive 
immunization to determine whether vaccination of dams with the E. coli O157 adhesin protein, 
intimin O157, would reduce E. coli O157:H7 colonization and intestinal damage in neonatal 
piglets.  Results indicated that vaccinated dams had colostral anti-intiminO157 titers greater than 
100,000 and piglets that were nursing from vaccinated dams did not show signs of colonization 
of E. coli O157 10 days after inoculation (Dean-Nystrom et al., 2002).   
Two other vaccines were developed and tested in hopes of reducing bacterial colonization of 
E. coli O157:H7. The first vaccine was developed by Konnadu et al. in 1999 and consisted of a 
detoxified lipopolysaccharide which was conjugated with a nontoxic B subunit of shiga-toxin 1.  
The second vaccine which was developed by Dziva et al. in 2007 was comprised of EspA, a 
Type III secretion protein (Konnadu et al., 1999; Dziva et al., 2007).  Both vaccines were 
successful at promoting an immune response against the antigens of interest, yet the vaccine 
containing EspA was not effective in protecting calves against intestinal colonization of E. coli 
O157:H7 upon experimental infection.        
 Potter et al. in 2003 conducted an efficacy trial testing an additional experimental vaccine 
targeting the type III secretion system of E. coli O157.  Researchers found that orally inoculated 
calves that were vaccinated with type III secretion proteins elicited an immune response and 
stopped shedding E. coli O157:H7 earlier than calves that were vaccinated with a placebo.  In 
2005, this vaccine was administered at a lower protein concentration to cattle at eight feedlots in 
Alberta, Canada and based on the results, scientists found that the pen prevalence was highly 
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variable (ranging from 0% to 80% at arrival, to 0% to 87% at revaccination, and 0% to 90% prior 
to slaughter) amongst both treatment groups (Type III vaccinates vs placebo controls) suggesting 
that the vaccine was not as efficacious in a natural feedlot setting (Van Donkersgoed et al., 
2005).   
E. coli O157:H7 SRP® vaccine 
A recently developed vaccine that selectively targets the pathway at which bacteria acquires 
its nutrients was designed to reduce E. coli O157 in cattle by targeting siderophore receptors and 
porin proteins of gram negative bacteria (Emery et al., 2000).  Iron is an essential nutrient for the 
growth and colonization of gram negative bacteria. Under low iron conditions, pathogenic 
bacteria produce a high affinity iron transport system to transport this required nutrient into the 
bacterial cell (Neilands, 1995).  This siderophore receptor and porin protein-based (SRP) vaccine 
uses purified siderophore receptor and porin proteins to promote an immune response in cattle.   
Siderophores are low molecular weight organic molecules that complex with ferric iron 
(Fe
3+
) in tissues of the host and supply it to the bacterial cell.  Siderophores bind with the 
siderophore receptors located on the outer membrane of the bacterial cell and allow for the 
passage of iron into the cell.  Once the iron has reached the periplasmic space, it is reduced to the 
ferrous form (Fe
2+
) to be used for the metabolic function (Prescott, 2005).  Porin proteins, such 
as OmpA, OmpC, OmpD, and OmpF, are outer membrane proteins of certain gram negative 
bacteria that are expressed with or without the presence of iron (Emery et al., 2000).  Porins 
often share a strong structural resemblance and may have slight sequence homology (Cowan et 
al., 1992).   
 The immunized animal produces anti-SRP antibodies which bind to the siderophore receptors 
and porins present on the outer membrane of the bacterial cell and block iron from being 
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transported into the cell.  The blocking of this nutrient essentially starves the bacteria and further 
colonization of this organism is greatly reduced.  
 SRP technology has been utilized in several species for the control of gram negative bacterial 
pathogens in the gut.  Field trials performed to aid in the development of an E. coli SRP vaccine 
to combat E. coli infections in turkeys showed that turkeys vaccinated with the E. coli SRP 
vaccine had an increase in antibody titers throughout a ten week period without revaccination 
(Emery et al., 2000).  E. coli SRP vaccinated turkeys not only had decreased mortality rate 
(38.5%, P < 0.01) and decreased carcass condemnation (31%, P<0.01), but, also, had increase in 
weight gain at harvest (9.3%, P < 0.01) when compared to the non-vaccinated controls (Emery et 
al. 2000).   
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SUMMARY 
 
Beef products have been commonly linked to several reported cases of human illness due 
to Escherichia coli O157:H7 infections (LeJeune and Wetzel, 2007).  Pre-harvest, along with 
post-harvest control of this food-borne pathogen is important in providing a safe product for the 
consumer.  The pre-harvest strategies must balance the implementation cost along with efficacy 
of the intervention.  The use of vaccination to prevent pathogenic colonization and fecal 
excretion in cattle may be the most efficient pre-harvest intervention strategy for reducing E. coli 
O157:H7 in cattle. This is due to the familiarity by cattle producers, ease of acceptance, and 
ready incorporation into existing vaccination practices (Lonergan and Brashears, 2005). 
A siderophore receptor/porin protein-based (SRP) vaccine was developed as an attempt 
to reduce human illness associated with E. coli O157:H7. Experimental trials used to evaluate the 
efficacy of this novel vaccine where performed in hopes of reducing prevalence and colonization 
of E. coli O157:H7 in cattle. Therefore, the objective of this thesis is to evaluate the ability of the 
E. coli SRP vaccine to reduce E. coli O157:H7 in cattle utilizing a challenge model and a feedlot 
setting.   
 
 
                         
 
 
 
 24 
  
CHAPTER 2 -  Siderophore Receptor/Porin Proteins-based 
Vaccination Reduces Prevalence and Shedding of Escherichia coli 
O157:H7 in Experimentally Inoculated Cattle 
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ABSTRACT 
 
The efficacy of a vaccine containing outer membrane siderophore receptor and porin (SRP) proteins 
in reducing prevalence of E. coli O157:H7 was evaluated in cattle inoculated with E. coli O157.  Thirty, 
calves were randomly assigned to one of two groups and administered subcutaneously, on days 1 and 
21, either a placebo (control) or a vaccine.  Blood was collected weekly to monitor the serum anti-SRP 
antibody titers.  Two weeks after the second vaccination, calves were orally inoculated with a mixture of 
five strains of nalidixic acid-resistant (NalR) E. coli O157:H7.  Fecal samples and rectoanal mucosal 
swabs were collected daily for the first 5 days, and three times a week for the following four weeks to 
determine the presence and enumerate fecal concentration of NalR E. coli O157:H7.  Calves were 
necropsied on day 35 to collect gut contents and tissue swabs to determine presence and concentration 
of NalR E. coli O157:H7.  Vaccinated cattle had significantly higher anti-SRP antibody titers than the 
control with a significant treatment by week interaction (P < 0.01).  Vaccination of cattle with the SRP 
tended to (P = 0.10) decrease fecal concentration of E. coli O157:H7.  The number of calves that were 
culture positive for E. coli O157, were lower (P= 0.07) in vaccinated group compared to the control.  
The novel E. coli O157:H7 SRP vaccine appears to be effective in reducing prevalence and fecal 
concentration of E. coli O157 in cattle orally inoculated with NalR E. coli O157:H7and may be useful as 
a possible prehavest intervention strategy.  
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INTRODUCTION 
 
Escherichia coli O157:H7 is a foodborne pathogen that causes hemorrhagic colitis of 
varying severity in humans, particularly in children and elderly it could lead to a serious 
condition called hemolytic uremic syndrome (Park et al., 1999; Karmali, 2005).  Cattle 
gastrointestinal tracts, particularly the hind gut, are the main reservoir and the organism is shed 
in the feces (Rasmussen et al., 2001; Bach et al., 2002).  The primary site of E. coli O157 
colonization in cattle has been shown to be the mucosal epithelium, proximal to the rectoanal 
junction, at the terminal rectum (Naylor et al., 2003; Low et al., 2005).  Swabbing this region 
with a foam-tipped applicator, called rectoanal mucosal swab (RAMS), has been shown to be a 
more sensitive sampling method for detecting E. coli O157 in cattle (Rice et al., 2003; 
Greenquist et al., 2004; Davis et al., 2006). 
Prevalence of E. coli O157 in cattle is variable among herds and individual animals, and 
feedlot cattle prevalence ranges from 10 to 28% and may be as high as 80% in the summer 
months (Elder et al., 2000; Gansheroff and O’Brien, 2000; Sargeant et al., 2003).  Most 
incidence of E. coli O157:H7 illnesses have been associated with cattle feces contaminating food 
directly (ground beef) or indirectly (juices, produce, other foods, and water) (Besser et al., 1999). 
Pre-harvest prevalence in cattle is associated with subsequent likelihood of post-harvest 
contamination of carcasses (Elder et al., 2000).  Therefore, efforts to reduce carriage in harvest 
ready cattle will likely reduce the proportion of carcasses that are contaminated with E. coli 
O157:H7.  Furthermore, interventions used to reduce shedding of this pathogen will also lower 
contamination of the pathogen to the environment.   
Iron is an essential nutrient for all Gram negative bacteria including E. coli O157:H7 (Bolin 
and Jensen, 1987).  A recently developed method that reduces the ability of gram-negative 
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bacteria to acquire iron (Emery, et al., 2000) may be a practical intervention to reduce infections 
with gram negative organisms.  Under low iron conditions, pathogenic bacteria, including E. 
coli, have evolved high affinity iron transport systems, such as ferric iron chelaters or 
siderophores, iron regulated outer membrane proteins (IROMPs), and siderophore receptor 
proteins (SRP), which are receptors for the siderophores on the outer membrane of the bacterial 
cell (Bolin and Jensen, 1987).  Siderophores are low molecular weight organic molecules that 
complex with ferric iron (Fe
3+
) in tissues of the host and supply it to the bacterial cell.  
Siderophores bind with the siderophore receptors located on the outer membrane of the bacterial 
cell and allow for the passage of iron into the cell.  Once the iron has reached the periplasmic 
space, it is reduced to the ferrous form (Fe
2+
) to be used for the metabolic function (Prescott, 
2005).  Porin proteins, such as OmpA, OmpC, OmpD, and OmpF, are outer membrane proteins 
of certain gram negative bacteria that are expressed with or without the presence of iron (Emery 
et al).  Porins often share a strong structural resemblance and may have slight sequence 
homology (Cowan et al.).   
Immunization that effectively targets the siderophore receptor and porin systems of E. coli 
O157:H7 should restrict iron transport into the bacterial cell.  The purpose of this study, 
therefore, was to evaluate the efficacy of an experimental vaccine containing E. coli O157:H7 
derived siderophore receptor and porin proteins in reducing prevalence and shedding of this 
pathogen in cattle that were orally inoculated with E. coli O157:H7.    
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MATERIALS AND METHODS 
 
 Cattle. Thirty, three or four-month old, mixed breed beef calves (182 ± kg) were used for 
this study.  The calves on arrival were vaccinated with a Mannhiemia haemolytica bacterin with 
leukotoxin and 7-way clostridial bacterin (One Shot Ultra 7; Pfizer Animal Health, Kalamazoo, 
MI.; lot#1478032) and a modified live viral BVD type I and II, IBR, PI-3 and BRSV vaccine 
(Bovi-Shield Gold 5; Pfizer Animal Health, lot#1479203).  Tilmicosin was injected 
subcutaneously (Micotil 300; Elanco Animal Health, Greenfield, IN.: lot#41820A) and an 
endectocide (Dectomax; Pfizer Animal Health, lot#KST01311) was also injected subcutaneously 
to each calf.  Calves were allowed to acclimatize as a herd for approximately two months.  The 
calves were fed group fed a commercial pelleted diet (Premium Starter 14, Wildcat Feeds, 
Topeka, KS) at approximately 3.1 kg per head per day and were allowed ad libtum access to 
brome grass hay and water throughout the study.   
Approximately one month later, calves were randomly assigned to one of two treatment 
groups: 1) control that received a placebo (adjuvant only) or 2) treatment that received an 
experimental SRP E. coli O157:H7 vaccine (Epitopix LLC., Willmar, MN).  There were fifteen 
calves in each group and the placebo or vaccine was administered subcutaneously on days 1 
and 21.  One week after the second injection (day 28), the calves were moved to a BSL-2 
facility at Kansas State University and housed individually in pens with walls separating each 
pen.  Each pen contained woodchip bedding, plastic buckets for drinking water, and individual 
feed bunks.  Calves were continued on their starter ration diet (3.1 kg per head per day) and 
drinking water was provided ad libitum.  On day 36, calves in both groups were orally 
inoculated, via gastric tube, with a mixture of five strains of E. coli O157:H7.  The animal 
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housing and management procedures used in this study were approved by the institutional 
Animal Care and Use Committee. 
 
Preparation of E. coli O157:H7 inoculum. Five strains of E. coli O157:H7 (FRIK920, 
FRIK1123, FRIK2000, 01-2-10561, and 01-2-08970), previously isolated from dairy or feedlot 
cattle feces (Kim et al., 1999; Sargeant et al., 2003), were made resistant  to nalidixic acid (50 
µg/ml; Nal
R
).  The stored strains were streaked onto sorbitol MacConkey agar (BD, Franklin 
Lakes, NJ) containing cefixime (50 ng/ml), potassium tellurite (2.5 μg/ml) (CT-SMAC), and 
supplemented with nalidixic acid (50 μg/ml) (CT-SMAC-N).  After 24 h incubation, single 
colony of each of the five strains was subcultured into 10 ml of tryptic soy broth (TSB; BD).  
The broth was incubated overnight (14 to 18 h) and 1 ml of inoculum from each tube was 
transferred to 250 ml-pyrex bottles  (Fisher, Palatine, IL) containing 100 ml of TSB, incubated 
for approximately 7 h and then pooled in a sterile 4 liter-pyrex bottle.  Just prior to oral 
inoculation, 5 ml of the pooled culture was mixed with 195 ml of 1% sterilized skim milk (EMB, 
Gibbstain, NJ).  A plate count of the pooled mixture was done by spread plating onto 
MacConkey agar (BD) and incubated overnight to determine the final concentration of cells in 
the inoculum.  The final concentration of the inoculated skim milk was 1.5 x 10
9
CFU/ml and 
each calf received a dose of 7.5 x 10
9
CFU.   
 
 Samples and sampling schedule. Fecal samples were collected from each calf on the 
morning prior to oral inoculation with Nal
R
 E. coli O157:H7, which was 14 days after the second 
vaccination.  After oral inoculation, fecal samples and RAMS were collected from each calf 
daily for the first five days , and subsequently three times a week (Monday, Wednesday and 
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Friday) for the following 4 weeks to test for the presence and determine the concentration of 
Nal
R
 E. coli O157:H7.  Fecal samples were collected rectally and placed in Whirl-Pak bags 
(Nasco, Ft. Atikson, WI).  Rectoanal mucosal swab sample was collected, using a sterile, foam-
tipped applicator (VWR International, Buffalo Grove, IL), which was inserted approximately 2 
to 5 cm into the anus of each calf to gently scrape the epithelium of the rectoanal junction with 
minimal amounts of fecal contamination of the swab (Rice et al., 2004; Greenquist et al., 2005).  
The swabs were immediately placed in culture tubes containing 3 ml of Gram-Negative (GN) 
broth (BD) with cefiximie (0.05 mg/liter), cefsulodin (10 mg/liter), and vancomycin (8 mg/liter; 
GNccv; Greenquist et al., 2005).  Both fecal samples and swabs were held on ice and transported 
to the laboratory and processed within an hour after collection. 
Blood samples were collected from each calf on day 1, just prior to the first vaccination 
(week 0), and thereafter at weeks 1, 2, 3 and 5, to monitor anti-SRP antibody titers in control and 
vaccinated cattle.  The blood was transferred to the lab on ice, centrifuged for 10 min at 1,000 
rpm, and serum was collected from each sample and placed in sterile cryogenic vials.  The 
samples were shipped on ice to Epitopix LLC., for anti-SRP antibody analysis.    
 
Necropsy examination.  At the end of the study (day 35 following oral challenge), calves 
were euthanized and necropsied in the Kansas State University Veterinary Diagnostic 
Laboratory.  Approximately 5 g of gut contents (rumen, omasum, abomasum, cecum, colon, and 
rectum) and tissue swab samples with foam-tipped applicators (gall bladder and rectoanal 
mucosa) were collected from each animal.  The tissue swabs were immediately placed in 3 ml 
GNccv tubes.  The gut contents in Whirl-Pak bags and tissue swabs in tubes were transported to 
the laboratory and analyzed to determine presence and concentration of Nal
R
 E. coli O157:H7.  
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 Detection of E. coli O157 in pre-challenge fecal samples. Approximately 2 g of feces 
was placed in a tube containing 18 ml of GNccv broth.  Fecal suspensions in the broth were 
vortexed for 1 min and incubated for 6 h at 37˚C.  The enriched fecal suspensions were then 
subjected to immunomagnetic separation (IMS; Dynal, Inc., New Hyde Park, NY) and spread-
plated onto CT-SMAC.  Plates were incubated overnight (16 to 18 h) and for each sample up to 
six sorbitol negative colonies were streaked onto blood agar plates (Remel, Lenexa, KS) and 
incubated for 12 to 18 h at 37˚C.  Colonies on blood agar plates were tested for indole 
production, O157 antigen using latex agglutination (Oxoid Limited, Basingstoke, Hampshire, 
England), and species confirmation was performed using API strips (Rapid 20E; Biomerieux, 
Inc., Hazelwood, MO). 
 
 Detection and quantification of NalR E. coli O157:H7 in post-challenge fecal, 
RAMS, and necropsy samples. Fecal or gut content (necropsy) samples were kneaded for 20 
to 30 sec and approximately 2 g of each sample was placed in pre-weighed tubes containing 18 
ml of GNccv broth.  The tubes were reweighed to determine the amount of samples.  The fecal 
suspensions or swab samples were vortexed for 1 min and 0.1 ml was pipetted into the first well 
of a 2.4 ml well capacity, 96 well Microtiter block (Corning Inc., Corning, NY) containing 0.9 
ml of buffered peptone water (Sigma-Aldrich, St. Louis, MO) dilution blank per well.  Serial 10-
fold dilutions were made and 100 μl of the appropriate dilutions were spread plated onto CT-
SMAC-N agar and incubated for 24 h at 37˚C.  After incubation, sorbitol-negative colonies with 
morphology characteristics of E. coli O157: H7 were counted and recorded.  A maximum of 
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three colonies per sample were collected, streaked onto blood agar, and incubated for 24 h at 
37˚C and tested for indole production and for the O157 antigen using latex agglutination.   
The detection limit of the direct plating method for Nal
R
 E. coli O157:H7 was 10
2
 CFU 
per g of sample.  Therefore, to detect low numbers of organisms (< 10
2 
/g), an enrichment step 
was completed for each fecal, RAMS, gut content or tissue swab sample collected at necropsy 
(2.0 g in 18ml or swabs in 3 ml GNccv broth) by incubating the tubes for 6 h at 37˚C.  After 
incubation, 1.0 ml of enriched broth was transferred to another 9.0 ml GNccv broth and 
incubated overnight 18-24 h at 37˚C.  After incubation, 100 μl was spread plated onto CT-
SMAC-N agar and incubated for 24 h at 37˚C.  A maximum of three sorbitol-negative colonies 
per sample were transferred to blood agar plate, incubated for 24 h at 37˚C and tested for indole 
production and for the O157 antigen by latex agglutination. 
 
 Determination of anti-SRP antibody concentration in serum.  Ninety-six well plates 
(Immulon-2 ELISA plates, Dynatech Laboratories, Chantily, VA) were coated with E. coli 
O157:H7 SRP antigen diluted in a coating buffer (1.59 g/liter Na2CO3, 2.93 g/liter NaHCO3, pH 
9.6).  The total antigen volume to coat each well was 100 μl.  The antigen was allowed to bind to 
the plate for 2 h on a rotator at 37°C.  Unbound antigen was removed from the plate and replaced 
with a blocking buffer (8.0 g/liter NaCl, 0.2 g/liter KCl, 1.44 g/liter Na2HPO4, 0.24 g/liter 
KH2PO4, 20 ml/liter fish gelatin).  The plate was placed at 4°C overnight on a rotator.  Serum 
from a calf that was hyper-immunized with the E. coli O157:H7 SRP vaccine was used as a 
positive control.  The positive control sera and test sera samples were added to the plate in 
duplicate.  One-hundred μl of each serum was added to the well at 1:50 dilution in phosphate 
buffered saline.  The sera samples were incubated on the plate for 1 h on a rotator at 37°C.  The 
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serums were then removed and the plate was washed three times with wash buffer (8.0 g/liter 
NaCl, 0.2 g/liter KCl, 1.44 g/liter Na2HPO4, 0.24 g/liter KH2PO4, 5 ml/liter Fish gelatin, 0.5 
ml/liter Tween-20).  A 1:15,000 dilution of alkaline phosphatase coated anti-bovine IgG H & L 
conjugate (Sigma-Aldrich, St. Louis, MO) was added to each well and the conjugate was 
incubated for 1 h with rotation at 37°C.  The conjugate was then removed and the plate was 
washed three times with wash buffer.  One-hundred μl of 4-Nitrophenyl phosphate (PNPP) 
substrate, prepared according to manufacturer’s instructions (Sigma-Aldrich), was added to each 
well and incubated on a rotator at 37°C for 30 min.  The absorbance of each well was determined 
with a spectrophotometer at a 405 nm wavelength.  The blank wells were subtracted from all 
sample wells so that the actual sample absorbance could be determined.  Results for samples 
were then determined by taking the absorbance of the unknown sample and dividing it by the 
absorbance of the standard positive serum to get a sample to positive (S:P) ratio.   
 
 Statistical analysis.  Analysis of variance was performed using commercially available 
statistical analysis software (SAS System for Windows, Version 9.1, SAS Institute, Cary, NC) to 
analyze fecal or gut contents Nal
R
 E. coli O157:H7 concentrations.  Bacterial counts were log10 
transformed before analysis.  Data were analyzed as a repeated measure design.  The statistical 
models included fixed effects of vaccination, sampling day, and the two-way interaction between 
vaccination and sampling day.  The random effect consisted of experimental animal within 
treatment.  Paired t-tests were used to determine statistical significance between treatment 
groups, sampling days or the interaction of treatment and sampling day.  Binomial data (presence 
or absence of E. coli O157:H7 by enrichment) were analyzed using logistic regression.  Initially, 
the interaction between treatment and day was assessed and if this interaction was not 
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statistically significant, it was not included in final models.  Final logistic regression models 
included treatment and sampling day as main effects and repeated measures on animal was 
accounted for because of the lack of independence of these samples.  Logit models in PROC 
GENMOD of SAS, were used to analyze the necropsy data with the numerator being the number 
of positive samples taken from the eight sampling sites and the denominator being the total 
samples collected for each animal (n=8). 
 
RESULTS 
 
 Analysis of fecal samples collected just prior to oral inoculation revealed that two calves in 
the control group were culture positive for E. coli O157.  No RAMS sample was colleced before 
the inoculation.  Statistical analysis of the fecal concentration data, after oral inoculation, of the 
two culture positive cattle were not different (P = 0.87) from the remaining cattle in the control 
group.  Also, statistical analysis of the fecal concentration data in the control and vaccinated 
cattle showed only a small difference in with (P = 0.10) or without (P = 0.12) inclusion of the 
two culture positive cattle.  Therefore, we decided to include the two culture positive cattle in all 
subsequent data analyses.  
 
 Antibody response in the control or vaccinated group.  The mean and standard errors of 
anti-SRP antibody titers (serum to standard positive ratio) for each treatment group before 
vaccination (week 0), after first vaccination (weeks 1, 2, and 3), and after the second vaccination 
(week 5) are shown in figure 1. Before the first injection, both groups had low but similar 
antibody titers.  There was a significant increase (P = 0.01) in the anti-SRP antibody titer in the 
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vaccinated group in all samples collected after the first vaccination.  There was no change in 
anti-SRP antibody titer in the control group during the study (Figure 2-1).  Therefore, there was a 
treatment by day interaction (P < 0.01). 
 
Figure 2-1 Anti-siderophore-porin (SRP) antibody response 
 
 Figure 2-1 Anti-siderophore-porin (SRP) antibody response in control (open circles) or vaccinated (closed circles) 
cattle before first vaccination (week 0), after first vaccination (weeks 1, 2, and 3), and after second vaccination 
(week 5).  Cattle were vaccinated on weeks 0 and 3 (Arrows).  S/P represents the ratio of the absorbance of the 
unknown sample divided by the absorbance of the standard positive serum.   
 
 
E. coli O157 in fecal or RAMS samples in the control or vaccinated group. 
Average initial concentrations of Nal
R
 E. coli O157:H7 in fecal samples of both groups were in 
the range of 10
3
 to 10
5 
CFU/g during the first 4 days following oral challenge (day 1) with 10
10 
per animal (Figure 2.2).  Fecal concentrations (log10 CFU/g) of Escherichia coli O157 in 
control (open circles) or vaccinated (closed circles) cattle following oral challenge (day 0) with 
nalidixic acid-resistant Escherichia coli O157. 
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Figure 2-2 Fecal concentrations (log10 CFU/g) of Escherichia coli O157 
 
Figure 2-2 Fecal concentrations (log10 CFU/g) of Escherichia coli O157 in control (open circles) or vaccinated 
(closed circles) cattle following oral challenge (day 0) with nalidixic acid-resistant Escherichia coli O157. 
 
Typically, after day 9, the mean counts were in the range of 10
1 
to 10
2
 CFU per g of feces in both 
groups.  On most sampling days, the mean fecal counts of the vaccinated group appeared to be 
lower than the control group.  However, the difference in fecal concentrations between the 
control and vaccinated group was only a trend with a treatment effect of P = 0.10.   There was a 
significant day effect (P = < 0.01) but no significant treatment and day interaction (P = 0.25).  
Therefore, the mean counts of Nal
R
 E. coli O157:H7 of all sampling days (days 1 to 32) were 
compared between the two groups and was 1.87 CFU/g of feces in the control vs. 1.57 CFU/g of 
feces in the vaccinated group (Figure 2-3).   
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Figure 2-3 Mean fecal concentration (log10 CFU/g) in the control or vaccinated group. 
 
Figure 2-3 Overall average fecal concentration (log10 CFU/g) in the control or vaccinated group.    
 
Overall, the number of cattle culture positive for Nal
R
 E. coli O157:H7, based on fecal sample 
analysis was lower (P = 0.05) in the vaccinated group compared to the control, but the vaccine 
effect was only a trend (P = 0.11), based on RAMS sample data (data not shown).  However, the 
number of cattle culture positive based on fecal or RAMS sample data tended to be lower (P = 
0.07) for the vaccinated cattle compared to the control cattle (Figure 2-4).  
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Figure 2-4 The number of cattle culture positive for nalidixic acid-resistant Escherichia coli 
O157 
 
Figure 2-4 The number of cattle culture positive for nalidixic acid-resistant Escherichia coli O157 in fecal or 
rectoanal mucosal swab samples from days 1 to 32 in control (open bars) and vaccinated (closed bars) cattle 
following oral challenge with nalidixic acid-resistant Escherichia coli O157. 
 
 Because, the number of cattle culture positive, regardless of fecal or RAMS sample analysis, 
was 14 or 15 (90 to 100% of cattle) until day 9 of the post challenge period in each group, we 
statistically analyzed fecal concentrations data from days 11 to 32.  The analysis showed that the 
mean daily fecal concentration in vaccinated cattle tended to be lower (P = 0.07) than the control 
group (Figure 2-5). 
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Figure 2-5 Fecal concentrations (log10 CFU/g) of Escherichia coli O157 from day 11 to 32 
following oral challenge with nalidixic acid-resistant E. coli O157. 
 
Figure 2-5 Fecal concentrations (log10 CFU/g) of Escherichia coli O157 in control (open circles) or vaccinated 
(closed circles) cattle following oral challenge with nalidixic acid-resistant Escherichia coli O157, from day 11 to 
32 following oral challenge with nalidixic acid-resistant E. coli O157. 
 
E. coli O157 in necropsy samples in the control or vaccinated group. Cattle 
vaccinated with the SRP E. coli O157:H7 vaccine had fewer number of cattle culture positive for 
E. coli O157:H7 in cecal (P = 0.06), colon (P = 0.05), and rectal contents (P = 0.06) compared to 
the control cattle administered with a placebo (Figure 2-6). 
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Figure 2-6 The number of cattle culture positive for Escherichia coli O157 at necropsy.  
 
Figure 2-6 The number of cattle culture positive for Escherichia coli O157 in gut contents or tissue swab samples 
collected during necropsy in control (open circles) or vaccinated (closed circles) cattle orally challenged with 
nalidixic acid-resistant E. coli O157. 
 
 In the control group, 11 of 15 (73.3%) cattle were culture positive for E. coli O157, whereas 
only 5 of 15 (33.3%) in the vaccinated group were culture positive.  There were no statistically 
significant differences between the number of cattle culture positive for E. coli O157:H7 in 
swabs collected from the rectoanal junction (P = 0.28) or the gall bladder mucosa (P = 0.31) 
between the treatment groups.  In fact, only one animal in the control group was culture positive 
for E. coli O157 in the gall bladder.  The necropsy data also illustrate that vaccination of cattle 
with SRP E. coli O157:H7 significantly decreased the concentration of E. coli O157:H7 (Figure 
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2-7) in cecal (P = 0.04), colon (P = 0.04) and rectal contents (P = 0.05), but had no significant 
effect on the concentration in the rectoanal junction (P = 0.15) or gall bladder mucosa (P = 0.17).   
 
Figure 2-7 Concentration of Escherichia coli O157 (log10 CFU/g or swab) in gut contents or 
tissue swab samples at necropsy. 
 
Figure 2-7 Concentration of Escherichia coli O157 (log10 CFU/g or swab) in gut contents or tissue swab samples 
collected during necropsy in control (open bars) or vaccinated (closed bars) cattle orally challenged with nalidixic 
acid-resistant E. coli O157. 
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DISCUSSION 
 
 The severity of the E. coli O157:H7 infection in children and the elderly, availability of few 
therapeutic approaches, the general consumer’s concern about safety of food products, and cattle 
being a major reservoir have led to intensive preharvest and postharvest strategies to reduce or 
eliminate the organism in cattle (Besser et al., 1999; Callaway et al., 2004; Gyles, 2007; 
Koohmaraie et al., 2005; Lonergan and Brashears, 2005; Lejuene and Wetzel, 2007).  Preharvest 
reduction of E. coli O157:H7 in cattle requires targeted intervention strategies, which should 
reduce carcass contamination (Lonergan and Brashears, 2005) and the intervention strategy will 
have a distinct advantage over postharvest strategies in reducing potential transfer by direct 
contact or contamination of the environment including water and produce.  Several preharvest 
interventions have been evaluated and include feed management, prebiotics, direct-fed 
microbials, bacteriophage therapy, sodium chlorate, vaccination, and neomycin in the feed 
(Lejune and Wetzel, 2007; Lonergan and Brashears., 2005). 
 Vaccine technology offers an advantage because of familiarity by cattle producers and ease 
of acceptance and ready incorporation into existing vaccination practices (Lonergan and 
Brashears., 2005).  The technology offers a challenge , specifically priming the immune system 
to mount a protective immunity against an organism that is considered a commensal (Lejeune 
and Wetzel, 2007).  Generally, experimental vaccines have targeted against cellular components 
that are important for bacterial adherence to the intestinal epithelium, such as Type III secreted 
protein, Tir, (Potter et al., 2004), intimin protein (Dean-Nystrom et al., 2002), and the O157 
lipopolysaccharide (Konnadu et al., 1999).  The SRP based vaccine that contains outer 
membrane siderophore-receptors and porin proteins is a novel approach to deprive the cell of 
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iron, an essential nutrient for all gram negative bacteria, including E. coli (Bolin and Jensen, 
1987).   
This is the first study to report on testing the efficacy of injecting cattle with an E. coli 
O157:H7 SRP vaccine to reduce fecal shedding, fecal concentration, and gut colonization of E. 
coli O157:H7 in cattle.  Our method to use cattle orally inoculated with E. coli O157 to 
determine the vaccine efficacy has been used by others (Potter et al., 2004).  We assessed culture 
positive status of calves by both fecal and RAMS analyses.  The primary site of E. coli O157 
colonization in cattle has been shown to be the mucosal epithelium, 1 to 5 cm proximal to the 
rectoanal mucosal junction (Low et al., 2005; Naylor et al., 2003).  This swabbing of this region 
using a foam-tipped applicator has been shown to be a more sensitive sampling method for 
detecting E. coli O157 in cattle (Davis et al., 2006; Greenquist et al., 2005; Rice et al., 2003).  
Therefore, inclusion of RAMS technique allowed us to improve detection of culture status of the 
inoculated calves. 
The vaccine was effective in inducing anti-SRP antibodies in the vaccine group.  However, 
the difference in fecal concentration between the vaccine and control groups was only marginally 
significant (P=0.10).  In this study, 100% of calves in both groups were shedding E. coli 
O157:H7 in feces for the first 9 days.  Naylor et al (2003) observed that cattle after oral 
inoculation shed E. coli O157:H7 initially at a high concentration  (10
9
).  In our study, calves 
were shedding initially at a mean concentration of 10
5
 to 10
3 
and the wide distribution of data 
made the treatment effect harder to detect.  In instances where no variation in data occurs or data 
are completely separated, maximum likelihood-based models either fail to converge or when 
they do, they produce very unstable and imprecise estimates.  Therefore, a post proc analysis was 
performed of data on fecal concentration from 11 days post challenge, which showed a P value 
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of 0.07.  When we compared the number of calves culture positive for E. coli O157, regardless 
of the sampling technique (feces or RAMS), the vaccine group had fewer calves and lower 
concentrations in gut contents or tissues than the control cattle.  The difference in the number of 
calves between the two groups was also evident in samples collected from gut contents or tissues 
from necropsied cattle.  There were fewer calves culture positive and lower concentration in 
vaccinated group compared to the control. 
 Our study showed that the E. coli O157:H7 SRP vaccine could be used as an intervention 
strategy in live cattle to reduce fecal prevalence in cattle.  Decreasing the number of cattle 
contaminated with E. coli O157:H7 entering the slaughter house would lead to a decrease in 
contaminated beef.  Further research on the efficacy of the vaccine in a natural prevalence and 
feedlot operations must be performed to further evaluate the SRP technology. 
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CHAPTER 3 - Effect of siderophore receptor/porin proteins-based 
vaccination on prevalence of Escherichia coli O157:H7 in feedlot 
cattle 
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ABSTRACT 
 
Objective—To evaluate the efficacy of a siderophore receptor/porin proteins-based vaccine in 
reducing Escherichia coli O157:H7 in feedlot cattle. 
Animals—1,252 yearling steers and heifers. 
Procedures—Cattle were randomly divided into 20 pens, approximately 65 cattle per pen, and 
were administered either the E coli O157 SRP vaccine or a placebo on days 0 and 21.  Rectal 
fecal samples were collected on day 0, and pen floor samples were collected on days 21, 35, and 
70.  A simulated harvest was performed on day 85 to evaluate prevalence of E coli O157:H7 in 
rectal fecal samples, rectoanal mucosal swab (RAMS) samples, and hide swab samples.  Cattle 
were weighed on days 0, 21, and on the day of simulated harvest (day 85).  Amount of feed 
delivered to each pen on each day was recorded electronically. 
Results—There was a treatment effect (P = 0.04) on fecal prevalence of E coli O157:H7 
averaged over time with an overall 54% reduction in prevalence in the SRP vaccinated cattle 
compared to the control cattle.  Vaccination with SRP antigens decreased the prevalence of E 
coli O157 in fecal samples (P = 0.01) collected at simulated harvest and tended to decrease the 
prevalence on hide swab samples (P = 0.06).  Administration of SRP vaccine had no negative 
effect on the performance of feeder calves. 
Conclusions and Clinical Relevance—The E coli O157 SRP vaccine reduced prevalence of E 
coli O157 in feedlot cattle.  Because preharvest prevalence is associated with carcass 
contamination, the vaccine evaluated might be a potential intervention strategy to aid in the 
control of this pathogen. 
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INTRODUCTION 
 
Escherichia coli O157 is an on-going and important cause of food-borne illness in the United 
States
 
(CDC, 2006).  Infection with this pathogen leads to hemorrhagic colitis and, in some 
cases, particularly in children, hemolytic uremic syndrome (Park et al. al. 1999).  Escherichia 
coli O157 lives in the intestines of healthy cattle and fecal shedding of this organism is linked to 
the contamination of unpasteurized milk and fruit juices, ground beef, raw vegetables, and bodies 
of water, particularly streams and ponds
 
(Rasmussen et al. 2001).  Because E coli O157 
infections in the U.S. are linked to the consumption of contaminated food and water, efforts to 
develop pre- and post-harvest strategies to control this pathogen in cattle are ongoing 
(Koohmariae et al., 2005; Loneragan and Brashears, 2005; Lejeune and Wetzel, 2007). 
 Vaccines that induce a protective immunity against colonization of E coli O157 may offer 
distinct advantages because of likely acceptance by cattle producers and ready incorporation into 
existing vaccination practices (Lonergan and Brashears, 2005).  Generally, experimental E coli 
O157 vaccines have targeted against antigenic components that are important for bacterial 
adherence to the intestinal epithelium or virulence of the pathogen, such as Type III secreted 
proteins (Potter et al., 2004), intimin protein (Dean-Nystrom et al., 2002), and the O157 
lipopolysaccharide (Konnadu et al., 1999).  A novel method that reduces the ability of Gram-
negative bacteria to acquire iron (Emery, et al., 2000) may be an effective and practical 
intervention to reduce infections with Gram negative organisms.  Iron is an essential nutrient for 
the growth and colonization of Gram-negative bacteria and under low iron conditions, bacteria 
produce a high affinity iron transport system to bring the required nutrient inside the bacterial 
cell
 
(Neilands et al. 1995).  The SRP-based vaccine uses purified siderophore receptor and porin 
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proteins as antigenic components to induce an immune response in cattle (Emery, et al., 2000).  
The goal is that immunized animals produce anti-SRP antibodies which bind to siderophore 
receptors and porins on the outer membrane of the bacterial cell and block iron transport into the 
cell.  Blocking iron transport renders the bacteria at a competitive disadvantage in a mixed 
microbial environment
 
(Emery et al., 2000). 
 In a previous study, investigators reported that an SRP vaccination promoted an immune 
response and significantly reduced fecal shedding of E. coli O157:H7 in calves that were orally 
inoculated with naladixic acid resistant E coli O157:H7
 
(Thornton et al. 2006).  Further 
application of this vaccine in a feedlot setting was deemed necessary to evaluate the efficacy of 
this new intervention strategy.  Therefore, the objectives of this study were to examine the 
effects of the SRP vaccination on prevalence in feces and hide contamination of E coli O157:H7 
in feedlot cattle. 
MATERIALS AND METHODS 
Cattle-Twenty pens housing a total of 1,252 of yearling steers and heifers, approximately 
60 to 70 cattle per pen, were utilized to examine the effects of SRP E. coli vaccination on 
prevalence of E coli O157:H7 and on cattle performance.  The study was conducted in two 
feedlots located in Central Nebraska.  All cattle were processed at the feedlot in which the study 
was conducted or at a nearby facility prior to the beginning of the study.  Cattle were purchased 
in 10 groups and each group was of the same gender.  Purchased groups 1 to 7 were fed in one 
feedlot and groups 8 to 10 were fed in the second feedlot.   
Cattle within each purchased group were randomly assigned to one of two treatments: 1) 
injected subcutaneously with an SRP E. coli O157:H7 vaccine at 1,000μg/dose on days 1 and 21 
or 2) injected subcutaneously with a placebo containing physiological saline emulsified with a 
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commercial adjuvant (Emulsigen
a
) on days 1 and 21.  Cattle were assigned to treatments by 
alternately allocating five cattle to one treatment and the next five cattle to the second treatment, 
as cattle moved through the chute until all cattle in the purchased group were assigned. 
Cattle were taken to their home pens which were pipe and cable fenced with concrete fence-
line feed bunks, and float-controlled water troughs.  All cattle were weighed on days 0, 21 and 
85.  On day 85, cattle were brought through the processing barn and subjected to simulate 
harvest.  This was considered necessary because the end of the finishing period would have 
pushed the cattle toward the seasonal change from summer to fall.  Therefore, to decrease the 
risk of having fewer positive cattle, a simulated slaughter was opted to get a more appropriate 
prevalence. 
Cattle had ad libtum access to feed and water during the study. Because cattle were 
backgrounded and transitioned to a finish diet prior to arrival into the feedlots, all cattle were 
placed directly on the finish diet on day one of the study.  Cattle were fed a typical High Plains 
finishing diet (74.5% dry matter; 58 % corn, 30 % corn gluten feed, 6.5% alfalfa hay, and 5.5% 
was a supplement containing minerals, vitamins and antibiotics).  Cattle were fed a similar diet 
in both feedyards.  The feed was delivered to the pens in a feed truck with a mixer box mounted 
on load cells.  The amount of feed delivered was recorded at each feeding and feed records for 
each pen were recorded electronically on a computer to determine feed intake at pen level.  All 
research, feedlot, and laboratory personnel were blinded from treatment assignment throughout 
the study. 
 
Sampling procedures-Rectal fecal samples were collected on day 0 as cattle were 
processed and placed in separate, pre-labeled sterile whirlpack bags
b
.  On days 21, 35, and 70 of 
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the finishing period, approximately 150 g from each of twenty freshly voided fecal pats were 
collected from the floor of each pen and placed in separate pre-labeled, sterile whirlpack bags.  
All samples were placed in coolers on ice and transported to the Preharvest Food Safety 
Laboratory to be processed.  
Samples collected at stimulated slaughter consisted of rectal fecal, RAMS, and hide swab 
samples.  Samples were collected from 30 animals per pen (60 animals per replicate; 600 animals 
total) and the selection of animals from which samples were collected was dependent on the 
order in which the cattle entered the chute.  The first sample was collected from the second 
animal of each pen and then every 3
rd
 animal until 30 animals per pen had been sampled.  The 
RAMS samples were collected using a sterile, foam-tipped applicator
b
, which was inserted 
approximately 2 to 5 cm into the anus to gently scrape the mucosal epithelium proximal to the 
rectoanal junction
 
 (Rice et al. 2003; Greenquist et al., 2005).  The swabs were placed in culture 
tubes containing 3 mL of GNccv broth
c
.  Hide samples were collected using Nasco Speci-
Sponges
d
 moistened with 5 mL of GNccv broth.  A 1,000 cm
2
 area of hide along the back of 
each animal was swabbed in a “zig-zag” motion and placed into separate pre-labeled, sterile 
whirlpack bags (Elder et. al., 2000).  Approximately 150 g of fecal material was collected 
rectally from each animal and placed into separate, pre-labeled sterile whirlpack bags.  All 
samples were placed in coolers on ice and transported to the Preharvest Food Safety Laboratory 
for analysis. 
 
 Isolation of E coli O157-Approximately 1 g of each fecal sample was placed in a tube 
containing 9 mL of GNccv.  The fecal suspension in GNccv broth and RAMS samples 
(previously placed in 3 mL of GNccv broth) were vortexed for 1 minute and incubated for 6 
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hours at 37˚C.  Using a pre-calibrated omnispensee, 20 mL of sterile GNccv broth was added to 
each whirlpack back containing the hide samples.  Each bag was sealed and placed in the 
incubator for 6 hours at 37˚C.  All samples were then subjected to immunomagnetic separationf 
and spread plated onto sorbitol MacConkey agar supplemented with 50 ng/mL cefixime and 2.5 
μg/mL potassium tellurite.  Plates were incubated overnight (16 to 18 hours) at 37˚C and up to 
six sorbitol negative colonies from each plate were streaked on to blood agar
g
.  The plates were 
then incubated overnight at 37˚C.  Colonies on blood agar plates were tested for indole 
production and O157 antigen using latex agglutination
h
.  Species was confirmed by API
i
 and 
PCR was used to detect the eae (intimin), stx1 (Shiga toxin 1), stx2 (shiga toxin 2), hlyA 
(hemolysin), (Fagan et al. 1998) and fliC (flagella) (Gannon et al. 1996) genes in each isolate.  
Genes were determined using TaqMan E. coli O157:H7 detection kit
j
 and the ABI Prism® 7700 
Sequence Detection System
j
.  The amplified DNA fragments were gel electrophoresed using 2% 
(w/v) agarose
k
 and stained with ethidium bromide (0.5 μg/mL).  The gels were visualized under 
UV light and genes were detected under a Gel-Doc 2000 fluorescent imager
l
. 
 
Statistical analysis- The prevalence of E coli O157:H7 in feces (over sampling days and at 
simulated slaughter), RAMS, and hide swabs were the outcome variables of interest.  For each of 
these variables, pen-level binomial response variables were created and analyzed using mixed-
models logistic regression techniques in a commercially available statistical analysis software 
package
m
.  Replicate was included as a random variable in a random intercepts/slopes model.  
When analyzing pen-floor fecal samples, repeated measures methodology was used to account 
for within-pen dependency over time.  From the various models, least-squares means were 
computed, back-transformed to normal scale, and converted to risk.  From estimates of risk, 
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relative risk and vaccine efficacy was calculated.  Where significant effects were observed in the 
model, appropriate pair-wise comparisons of means were performed. 
 
RESULTS 
The average pen fecal prevalence of E coli O157:H7 in the SRP vaccinated and the control 
group on day 0 (before vaccination) was 12 and 13%, respectively.  Fecal prevalence of E coli 
O157 in samples collected after vaccination (days 21, 35, and 70), and at simulated slaughter 
(day 85) is shown in figure 3-1. 
Figure 3-1  Mean prevalence of Escherichia coli O157 in cattle feces  
 
Figure 3-1 Mean prevalence of Escherichia coli O157 in feces (proportion of cattle positive) on days 21, 35, 70 and 
85 (after vaccination) in placebo control (white bars) or E coli O157:H7 siderophore receptor and porin proteins-
based vaccination in cattle (gray bars). Day 85 was the day of simulated slaughter. 
 
No significant interaction of treatment by time was detected (P=0.56).  There were a significant 
treatment effect (P = 0.04), but an effect of sampling day was not detected (P = 0.07).  The 
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proportion of cattle culture positive for E coli O157:H7 in the feces averaged over sampling days 
was 1.6% for the SRP vaccinated group and 3.4% for the control (Figure 3-2).  
  
Figure 3-2  Mean prevalence (proportions of cattle positive) of Escherichia coli O157. 
 
Figure 3-2 Mean overall prevalence (proportions of cattle positive) of Escherichia coli O157 in placebo control 
(white bar) or E coli O157:H7 siderophore receptor and porin proteins-based vaccination in cattle (gray bar). 
 
At the time of simulated slaughter (day 85), cattle that received the SRP vaccine had 
decreased (P = 0.01) E coli O157:H7 positive fecal samples compared to cattle vaccinated with 
the placebo (7 vs. 16%, respectively).  The reduction in fecal prevalence of E coli O157 was 54% 
in the SRP vaccinated cattle compared to the control cattle injected with the placebo.  The mean 
prevalence of E coli O157:H7 in hide samples tended (P = 0.06) to be higher in cattle in the 
placebo group than in the SRP vaccinated group (Figure 3).  A difference between the two 
treatment groups in the likelihood of recovered of E coli O157:H7 from rectoanal mucosal swabs 
was not detected (P = 0.24).  The total number of cattle positive for E coli O157:H7 in at least 
one sample (feces, RAMS, or hide sample) at simulated harvest was fewer (P = 0.02) in the SRP 
vaccinated group compared to the the placebo group (Figure 3-3); vaccination with SRP and 
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porin-based antigens reduced the number of cattle culture positive for E coli O157 by 57.8% 
compared to the control cattle.  Out of the 226 E. coli O157 isolates, 72% (163/226), 66% 
(150/226), 70% (159/226) and 75% (170/226) contained the genes eaeA, stx2, hlyA, and fliC 
respectively.  
 
Figure 3-3 Mean overall prevalence of Escherichia coli O157 (proportions of cattle positive) 
at simulated slaughter. 
 
Figure 3-3 Mean overall prevalence of Escherichia coli O157 (proportions of cattle positive) in feces, rectoanal 
mucosa, hides, and cattle (feces, rectoanal mucosa, or hides) in placebo control (white bars) or E coli O157:H7 
siderophore receptor and porin proteins-based vaccination (gray bars). 
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The SRP-based E coli O157:H7 vaccination had no effect on average daily gain (P = 0.37), daily 
feed intake (P = 0.29), and on gain efficiency (P = 0.18) for the 85 days on feed (Table 3-1). 
 
Table 3-1 Effects of siderophore receptor and porin proteins (SRP)-based Escherichia coli 
O157:H7 vaccination on the performance of feedlot cattle. 
 
 
DISCUSSION 
Several pre- and postharvest exclusion strategies have been researched over the past 
decade in hopes of reducing or eliminating this microorganism in cattle (Besser et al., 1999, 
Callaway et al., 2004; Gyles, 2007; Koohmaraie et al., 2005; Loneragan and Brashears, 2005; 
Lejuene and Wetzel, 2007).  Preharvest intervention has a distinct advantage over post-harvest 
intervention in that it would not only reduce the risk for carcass contamination, but would also 
reduce the source of potential contamination to the environment.  Pre-harvest intervention 
strategies that are currently being tested include: diet manipulation, direct-fed microbials, 
 62 
bacteriophage therapy, prebiotics, antibiotics, such as neomycin, sodium chlorate, and 
vaccination (Loneragan and Brashears, 2005; Lejeune and Wetzel, 2007)  
Vaccine approach to reduce preharvest prevalence E coli O157:H7 in cattle would be 
advantageous to producers, because it could easily be incorporated into the existing vaccination 
practices of most feedlots.  However, vaccination against E coli O157:H7 can be quite 
challenging because the targeted organism is a commensal in cattle (Lejuene and Wetzel, 2007).  
Experimental vaccines for E coli O157:H7 have generally targeted the cellular components of 
the organism, such as the type III secretion protein, Tir, and the intimin protein, both of which 
would prevent bacterial adherence to the intestinal epithelium (Dean-Nystrom et al.,2002; Potter 
et al., 2004).  Konnadu et al., (1999) have tested a vaccine targeting the O-specific 
polysaccharide and Stx 1b subunit of E. coli O157.  This vaccine was intended to inactivate the 
lipopolysaccharide and further reduce colonization within the intestinal mucosa (Konnadu, et al. 
1999).  The SRP vaccine is comprised of siderophore-receptors and porin proteins that would 
provoke an immune response in cattle and deprive E coli O157:H7 of iron, an essential nutrient 
(Bolin and Jensen, 1987).  Antibody response in cattle to vaccination was not monitored in this 
study.  However, strong anti-SRP antibody response to vaccination was documented in our 
previous study (Thornton et al., 2006).  
The E coli O157:H7 SRP vaccine was previously tested in 4 month-old calves that were 
orally inoculated with a 5-strain mixture of nalidixic-acid resistant (Nal
R
) strains of E coli 
O157:H7 (Thornton, et al., 2006).  Results indicated that the vaccine was effective in reducing 
the concentration and number of calves shedding Nal
R 
E coli O157:H7 in the feces.  Cattle 
vaccinated with the SRP E coli O157:H7 vaccine also had a fewer number of cattle culture 
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positive for Nal
R
 E coli O157:H7 in cecal, colon, and rectal contents collected at necropsy 
compared to the control cattle administered with the placebo. 
Data in the current study showed that vaccinating cattle with the SRP E coli O157:H7 
vaccine reduced the percentage of cattle shedding E coli O157:H7 by over 50 %.  Other vaccine 
technologies, such as the vaccine targeting the type III secretion proteins of E coli O157:H7, 
showed mixed results when used in a commercial feedlot environment (Potter et al., 2004; Van 
Donkersgoed, 2005).  Potter et al. (2004) observed a 60% decrease  in cattle shedding E coli 
O157:H7 that were vaccinated three times with type III secretion proteins relative to non-
vaccinated cattle in a small pen study (24 pens, 2 treatments, 8 head/pen).  However, Van 
Donkergoed et al. (2005) evaluated the effects of the same vaccine in a large scale commercial 
feedlot setting and observed no difference in E coli O157:H7 prevalence in vaccinated vs. the 
non-vaccinated controls (Van Donkergoed et al., 2005).  Pen prevalence was highly variable 
ranging from 0% to 80% at arrival, to 0% to 87% at revaccination, and 0% to 90% prior to 
slaughter amongst both treatment groups (Type III vaccinates vs placebo controls) suggesting 
that the vaccine was not as efficacious in a natural feedlot setting (Van Donkersgoed et al., 
2005).  The SRP E coli O157:H7 vaccine, however, caused a significant decrease in fecal 
shedding and tended to decrease contamination on hides at simulated slaughter, which has not 
been documented by any other vaccine efficacy study performed in a commercial feedlot setting.  
Hancock et al. (1997) reported that the peak prevalence of E coli O157:H7 in North 
America occurs in the late summer and early fall months.  Although this study was conducted 
when the prevalence was historically highest (late summer), the overall prevalence of E coli 
O157:H7 in this study was quite low.  In 2001, prevalence of E. coli O157:H7 was evaluated in 
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29 pens of cattle from five feedyards in the midwest and the percent of cattle shedding the 
organism ranged from 0.7% to 79.8% with a median prevalence of 17.1% (Smith et al., 2001).   
A simulated slaughter was conducted on day 85, which was approximately one to four weeks 
before the animals were actually slaughtered.  This was performed to ensure that the appropriate 
samples from each group of cattle were collected before the seasonal decline in E coli prevalence 
occurred. E coli prevalence has been shown to decrease as the season changes from summer to 
fall (Bach et al. 2002; Smith et al., 2003).  
Simulated slaughter data showed that a treatment effect occurred when evaluating the 
prevalence of E coli O157 in fecal matter and on hides.  Hide swab samples were collected along 
the back region of each animal, which was where site-specific prevalence of E coli O157 was 
shown to be the highest (74%)
 
(Keen et al., 2002).  A strong correlation between prevalence of 
this organism in fecal samples and on hides
 
has been demonstrated (Elder et al., 2000).  Fecal 
prevalence at slaughter for both treatment groups combined was quite low (less than 6%; 1.6% in 
SRP vaccinated cattle and 4.0% in the control group), which was similar to results reported by 
Omisakin et al., in 2003, where prevalence at slaughter was 7.5%.   
Samples taken from the rectoanal mucosal region did not show significant treatment 
differences in prevalence of E coli O157:H7.  Rectoanal mucosa has been shown to be a 
preferred site of colonization in cattle (Naylor et al., 2003; Low et al., 2005). Rectoanal mucosal 
swabbing (RAMS) was more a sensitive sampling technique than the fecal culture method when 
examining the presence of E coli O157:H7
 
(Rice et al., 2003: Greenquist et al., 2005; Davis et 
al., 2005). Rice et al. (2003) have suggested that when collecting RAMS samples, the swabs 
must be minimally exposed to fecal material to reduce the risk of obtaining the intestinal natural 
flora.  It is possible that during the simulated slaughter, the rectoanal mucosal swab samples 
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were contaminated to the animal’s fecal matter, which allowed for competitive exclusion of the 
natural flora, thus eliminating the chance for detection of the organism of interest.  
Injection of cattle with the E coli O157:H7 SRP vaccine did not have an effect on feeder 
cattle performance.  Some vaccines have been shown to significantly (P < 0.05) increase average 
daily weight gain in animals, which was examined by Barling et al. in 2003 when beef feedlot 
steers were subcutaneously vaccinated against Neospora caninum
 
 (Barling et al. 2003). This 
improvement in performance is generally seen when the targeted organism is a pathogen of the 
animal receiving the vaccination.  E coli O157 is not a pathogen of cattle and, therefore, the E 
coli O157:H7 SRP vaccine not affecting cattle performance was not unexpected.  
 Vaccination of feedlot cattle with the E coli O157:H7 SRP vaccine reduced the prevalence of 
E coli O157 and did not affect overall cattle performance.  Pre-harvest control of food-borne 
pathogens decreases the potential for post-harvest contamination of beef products.  Use of the 
SRP E coli O157:H7 vaccine could be an appropriate tool to reduce food borne illnesses 
associated with food or water contaminated with cattle feces, without decreasing the efficiency 
of beef production.  
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FOOTNOTES 
 
a. MVP, Laboratories, Omaha, NE 
 
b. Fisher, Palatine, IL  
 
c. VWR International, Buffalo Grove, IL 
 
d. BD, Franklin Lakes, NJ. 
 
e. Nasco, Fort Atkinson, WI 
 
f. Wheaton, Millville, NJ 
 
g. Dynal, Inc. New Hyde Park, NY 
 
h. Remel, Lenexa, KS 
 
i. Oxoid Limited, Basingstoke, Hampshire, England 
 
j. Biomerieux, Inc., Hazelwood, MO 
 
k. PE Applied Biosystems, Foster City, CA 
 
l. Fischer Scientific, Pittsburgh, PA 
 
m. Bio-Rad, Hercules, CA 
 
n. SAS, version 9.1.3, SAS Institute Inc, Cary, NC. 
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ABBREVIATIONS 
 
SRP  Siderophore Receptor/Porin Proteins 
RAMS  Rectoanal Mucosal Swab 
GNccv  Gram Negative Broth supplemented with cefixime (0.05 mg/L), cefsulodin  
(10.0 mg/L), and vancomycin (8.0 mg/L)  
PCR  Polymerase Chain Reaction 
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CONCLUSION 
 
The Center for Disease Control (CDC) continues to report multi-state outbreaks of 
Escherichia coli O157:H7 infections which are consistently identified as being associated with 
its bovine reservoir.  Three separate outbreaks have been reported resulting in over 300 cases of 
hemorrhagic colitis, 41 cases of hemolytic uremic syndrome (HUS), and 3 deaths within the last 
two years.  This organism has not only caused human illness, but has also created an excessive 
amount of waste due to the recall of contaminated food products.  Best management practices 
should be implemented to reduce the prevalence of E. coli O157:H7 in the environment and 
reduce its existence in our food chain.  It becomes more apparent that the use of multiple forms 
of intervention must be used in the field to control contamination of beef products with E. coli 
O157:H7.  
Our preliminary studies showed that the E. coli O157:H7 SRP vaccine could be an 
effective tool in reducing prevalence and concentration of E. coli O157 in cattle.  In our 
challenge study, E. coli O157:H7 SRP vaccine was effective in reducing prevalence and fecal 
concentration of E. coli O157 in cattle orally inoculated with Nal
R
 E. coli O157:H7.  In our 
feedlot study, fecal prevalence of E coli O157:H7 averaged over time was reduced by 54% in the 
SRP vaccinated cattle compared to the control cattle.  Vaccination with SRP antigens decreased 
the prevalence of E coli O157 in fecal samples collected at simulated harvest and tended to 
decrease hide swab samples prevalence.  Administration of SRP vaccine had no effect on the 
performance of feeder calves. 
Vaccination of cattle with the E. coli SRP vaccine could be a possible strategy to 
reducing E. coli O157:H7 prevalence within a feedlot setting.  By using this strategy with good 
biosecurity practices, the concentration of the pathogen is greatly reduced both in the gut and in 
the feces thus reducing the spread of the organism in the environment.  Future research on the 
use of this novel vaccine is necessary to optimize E. coli O157:H7 control without decreasing 
cattle performance.                 
 
 
 
